Colorectal Cancer Trial, Recruiting NCT07087561 Sponsor: Xiaoqin Luo Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT07087561
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have a confirmed diagnosis of colon or rectal cancer (confirmed through laboratory or tissue testing)
  • People whose cancer is classified as stage IIa, IIb, or IIIa
  • People who are mentally alert and able to communicate
  • People who are willing to attend follow-up appointments and have a life expectancy of more than 6 months
  • People who have signed a consent form agreeing to take part in the trial

Who may not be able to join:

  • People whose nutritional risk score falls below a certain threshold on either the mPG-SGA or NRS-2002 screening tools (confirm with trial site)
  • People who have been diagnosed with AIDS
  • People who have previously had an organ transplant
  • People who are pregnant or breastfeeding
  • People who are currently taking part in another clinical trial that involves a treatment or intervention
  • People who are not able to carry out basic daily self-care independently
  • People who are unable to do any physical activity around the time of their surgery
  • People who have serious ongoing health conditions, such as uncontrolled heart disease or severe liver or kidney problems
  • People who are known to have an allergy or intolerance to any ingredient in the nutritional supplements being used in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8618802932796

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xiaoqin Luo
Registry
ClinicalTrials.gov
Start date
10 October 2024
Est. completion
10 October 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in Nutritional Status Assessed by Modified Patient-Generated Subjective Global Assessment (mPG-SGA); Change in Global Health Status Score on the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30); Change in Symptom Scores on the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30); Overall Survival (OS) in Cancer Patients; Progression-Free Survival (PFS) in Cancer Patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov